Skip to content
ppharmaranks
Menu

Genentech Inc

manufacturer

70/100

Genentech Inc is a manufacturer that makes prescription drugs. pharmaranks independently rates 31 of its products, with a composite rating of 3.5 out of 5 based on FDA regulatory (recall-safety) data.

Rated against independent sources·Last updated August 19, 2026·How we rate

Products (31)

Rx70/100

activase

Alteplase

(5 data points)
Price variesView
Rx70/100

avastin

Bevacizumab

(5 data points)
Price variesView
Rx70/100

cathflo activase

Alteplase

(5 data points)
Price variesView
Rx70/100

columvi

Glofitamab-Gxbm

(5 data points)
Price variesView
Rx70/100

cotellic

Cobimetinib Fumarate

(5 data points)
Price variesView
Rx70/100

enspryng

Satralizumab

(5 data points)
Price variesView
Rx70/100

erivedge

Vismodegib

(5 data points)
Price variesView
Rx70/100

evrysdi

Risdiplam

(5 data points)
Price variesView
Rx70/100

hemlibra

Emicizumab

(5 data points)
Price variesView
Rx70/100

herceptin

Trastuzumab

(5 data points)
Price variesView
Rx70/100

lucentis

Ranibizumab

(5 data points)
Price variesView
Rx70/100

lunsumio

Mosunetuzumab-Axgb

(5 data points)
Price variesView
Rx70/100

nutropin

Somatropin

(5 data points)
Price variesView
Rx70/100

nutropin aq

Somatropin

(5 data points)
Price variesView
Rx70/100

nutropin aq nuspin

Somatropin

(5 data points)
Price variesView
Rx70/100

nutropin aq pen

Somatropin

(5 data points)
Price variesView
Rx70/100

ocrevus

Ocrelizumab

(5 data points)
Price variesView
Rx70/100

ocrevus zunovo

Ocrelizumab and Hyaluronidase-Ocsq

(5 data points)
Price variesView
Rx70/100

phesgo

Pertuzumab, Trastuzumab, and Hyaluronidase-Zzxf

(5 data points)
Price variesView
Rx70/100

piasky

Crovalimab-Akkz

(5 data points)
Price variesView
Rx70/100

pulmozyme

Dornase Alfa

(5 data points)
Price variesView
Rx70/100

rituxan

Rituximab

(5 data points)
Price variesView
Rx70/100

rituxan hycela

Rituximab and Hyaluronidase (Human Recombinant)

(5 data points)
Price variesView
Rx70/100

rozlytrek

Entrectinib

(5 data points)
Price variesView
Rx70/100

susvimo

Ranibizumab

(5 data points)
Price variesView
Rx70/100

tecentriq

Atezolizumab

(5 data points)
Price variesView
Rx70/100

tecentriq hybreza

Atezolizumab and Hyaluronidase-Tqjs

(5 data points)
Price variesView
Rx70/100

tnkase

Tenecteplase

(5 data points)
Price variesView
Rx70/100

vabysmo

Faricimab-Svoa

(5 data points)
Price variesView
Rx70/100

xofluza

Baloxavir Marboxil

(5 data points)
Price variesView
Rx70/100

xolair

Omalizumab

(5 data points)
Price variesView

Genentech Inc’s FDA recall record

Every recall the FDA has published for a product we list under Genentech Inc. A count on its own says little — a company making more products will record more recalls — so the events themselves are shown, most recent first.

3 recalls on record3 Class II — temporary or reversible harm
  • XOLAIR20250730

    CGMP Deviations - Product was exposed to temperatures outside the product's labeled storage requirements.

  • XOLAIR20250730

    CGMP Deviations - Product was exposed to temperatures outside the product's labeled storage requirements.

  • CATHFLO ACTIVASE20240520

    Lack of Assurance of Sterility: Deformed stoppers observed during filling operations for Cathflo Activase.

Reviews

No reviews yet. Be the first to write one.

Write a review

Reviews are user opinions, not medical advice. Consult a licensed professional.

Frequently asked questions

What does Genentech Inc make?

Genentech Inc makes prescription drugs. pharmaranks independently rates 31 of its products — see the full list below.

How is Genentech Inc rated?

pharmaranks gives Genentech Inc a composite rating of 3.5 out of 5, based on FDA regulatory (recall-safety) data across its products. See the source breakdown on this page.